Frequently Asked Questions
Asia-Pacific Injectable Drug Delivery Market soars at a CAGR of 11.45% by 2029
Asia-Pacific Injectable Drug Delivery Market will be worth $297.31 billion by 2029
Asia-Pacific Injectable Drug Delivery Market covers Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific.
Asia-Pacific Injectable Drug Delivery Market Key Players are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, BD, SCHOTT AG, Gerresheimer AG, Alkermes, Eli Lilly and Company, Sandoz, Terumo Corporation, Ypsomed AG and Bespak Europe Ltd.,